This inventor holds 2 USPTO granted patents. Top assignee: Chong Kun Dang Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Jeong Mi Hah: Innovator in Antineoplastic Compounds
Introduction
Jeong Mi Hah is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antineoplastic agents. With a total of 2 patents, his work focuses on enhancing the efficacy and solubility of important compounds.
Latest Patents
His latest patents include innovative methods for preparing camptothecin compounds and their derivatives. These compounds are crucial in cancer treatment, as they exhibit improved water solubility and enhanced antineoplastic effects. The specific patents detail the manufacturing methods for camptothecin derivatives and pharmaceutically acceptable salts, which are vital for effective drug formulation.
Career Highlights
Jeong Mi Hah is associated with Chong Kun Dang Corporation, a leading pharmaceutical company in South Korea. His work at the company has been instrumental in advancing cancer treatment options through innovative drug development.
Collaborations
He has collaborated with notable colleagues, including Sang Sup Jew and Hee Soon Lee, to further enhance the research and development of pharmaceutical compounds.
Conclusion
Jeong Mi Hah's contributions to the field of pharmaceuticals, particularly in the development of camptothecin derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile